Jair Bar

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

Jair Bar

May 20, 2025, 07:03 | Insight

David Gandara: Clinical and Biological Implications of Plasma Proteomics in NSCLC Presented at AACR 2025

David Gandara, Co-Director of the Center for Experimental Therapeutics at the UC Davis Comprehensive Cancer Center,…

Feb 12, 2025, 16:19 | Science

Aakash Desai: ICB Retreatment in NSCLC - Who Benefits?

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn about recent…

Sep 24, 2024, 13:32 | Insight

Jarushka Naidoo: Stage III ALK+ NSCLC - consolidation ALK TKI vs Durvalumab vs Observation

Jarushka Naidoo shared on X: "Stage III ALK+ NSCLC: consolidation ALK Tyrosine Kinase Inhibitors versus…

Aug 29, 2024, 17:01 | Insight

Elad Sharon: Quite promising for c-MET over-expressing NSCLC

Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, shared a post by Giuseppe Banna, Consultant…

Aug 27, 2024, 22:06 | Insight

Giuseppe Banna: Promising results for Telisotuzumab Vedotin in advanced NSCLC

Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post on…

All: 5 Posts: 1 - 100

'

15 Posts Not to Miss from the 1st Day of ASCO 2025

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023